Retinoic acid receptor-β2 promoter methylation in random periareolar fine needle aspiration

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 4, 2005, Pages 790-798

  Bean, Gregory E ^a   Scott, Victoria ^a   Yee, Lisa ^b   Ratliff Daniel, Brooke ^a   Troch, Michelle M ^a   Seo, Pearl ^a   Bowie, Michelle L ^a   Marcom, Paul K ^a   Slade, Jaimie ^a   Kimler, Bruce F ^c   Fabian, Carol J ^c   Zalles, Carola M ^c   Broadwater, Gloria ^a   Baker Jr , Joseph C ^a   Wilke, Lee G ^a   Seewaldt, Victoria L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA 2; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CARCINOMA; CANCER RISK; CANCER STAGING; CARCINOMA IN SITU; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOLOGY; EARLY CANCER; FEMALE; GENE MUTATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; METHYLATION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TUMOR BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOGENICITY TESTS; FEMALE; HUMANS; METHYLATION; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, RETINOIC ACID; RISK FACTORS;

EID: 20144387394     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0580     Document Type: Article

References (40)

1. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
2. Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer 2002;38 Suppl 6:515-7.
3. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84.
4. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001;1:181-93.
5. Seewaldt VL, Johnson BS, Parker MB, et al. Expression of retinoic acid receptor β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 1995;6:1077-88.
6. Subbaramaiah K, Cole PA, Dannenberg AJ. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res 2002;62:2522-30.
7. Treuting PM, Chen LI, Buetow BS, et al. Retinoic acid receptor β2 inhibition of metastasis in mouse mammary gland xenografts. Breast Cancer Res Treat 2002;72:79-88.
8. Deng G, Lu Y, Zlotnikov G, et al. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-9.
9. Widschwendter M, Berger J, Daxenbichler G, et al. Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997;57:4158-61.
10. 1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ 1997;8:631-41.
11. Seewaldt VL, Caldwell LE, Johnson BS, et al. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. Exp Cell Res 1997;236:16-28.
12. Dietze EC, Caldwell LE, Marcom K, et al. Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300. Microsc Res Tech 2002;59:23-40.
13. Kopelovich L, Crowell JA, Fay JR. The epigenome as a target for cancer chemoprevention. J Natl Cancer Inst 2003;95:1747-57.
14. Sirchia SM, Ferguson AT, Sironi E, et al. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells. Oncogene 2000;19:1556-63.
15. Widschwendter M, Berger J, Hermann M, et al. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer. J Natl Cancer Inst 2000;92:826-32.
16. Esteller M, Silva JM, Dominguez G, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000;92:564-9.
17. Fackler MJ, McVeigh M, Evron E, et al. DNA methylation of RASSF1A, HIN-1, RAR-β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 2003;107:970-5.
18. Lapidus RG, Nass SJ, Butash KA, et al. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 1998;58:2515-9.
19. Lehmann U, Langer F, Feist H, et al. Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 2002;160:605-12.
20. Liu ZJ, Maekawa M, Horii T, et al. The multiple promoter methylation profile of PR gene and ERα gene in tumor cell lines. Life Sci 2003;73:1963-72.
21. Mancini DN, Rodenhiser DI, Ainsworth PJ, et al. CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 1998;16:1161-9.
22. Nass SJ, Herman JG, Gabrielson E, et al. Aberrant methylation of the estrogen receptor and E-cadherto 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 2000;60:4346-8.
23. Sathyanarayana UG, Padar A, Suzuki M, et al. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2003;9:6395-400.
24. Umbricht CB, Evron E, Gabrielson E, et al. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 2001;20:3348-53.
25. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000;92:1217-27.
26. Fabian CJ, Kimler BF. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention. Ann N Y Acad Sci 2001;952:44-59.
27. Dooley WC, Ljung BM, Veronesi U, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93:1624-32.
28. Sirchia SM, Ren M, Pili R, et al. Endogenous reactivation of the RARβ2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 2002;62:2455-61.
29. Evron E, Dooley WC, Umbricht CB, et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 2001;357:1335-6.
30. Zalles CM, Kimler BF, Kamel S, et al. Cytology patterns in random aspirates from women at high and low risk for breast cancer. Breast J 1995;1:343-9.
31. Stampfer MR. Isolation and growth of human mammary epithelial cells. J Tissue Cult Meth 1985;9:107-15.
32. Seewaldt VL, Mrozek K, Dietze EC, et al. Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis. Cancer Res 2001;61:616-24.
33. Seewaldt VL, Mrozek K, Sigle R, et al. Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis. J Cell Biol 2001;155:471-86.
34. Lehmann U, Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 2001;25:409-18.
35. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001;29:E65-5.
36. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002;21:5462-82.
37. Yang Q, Yoshimura G, Nakamura M, et al. Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor β2 expression in breast carcinoma. Breast Cancer Res Treat 2001;70:39-45.
38. Youssef EM, Lotan D, Issa JP, et al. Hypermethylation of the retinoic acid receptor-β(2) gene in head and neck carcinogenesis. Clin Cancer Res 2004;10:1733-42.
39. Breast Cancer Risk Assessment Tool [homepage on the Internet]. Bethesda: National Cancer Institute; c2000 [cited 2004 Oct 13]. Available from: http://bcra.nci.nih.gov/brc/.
40. Bondy ML, Newman LA. Breast cancer risk assessment models: applicability to African-American women. Cancer 2003;97:230-5.